We are live on ! Find out more
MNOV icon

MediciNova

35 hedge funds and large institutions have $6.78M invested in MediciNova in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $18K | Put options by funds: $3K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 3435 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.33% less ownership

Funds ownership: 9.86%9.53% (-0.33%)

7% less capital invested

Capital invested by funds: $7.25M → $6.78M (-$473K)

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
6
Reduced
13
Closed
4
Calls
$18K
Puts
$3K
Net Calls
+$15K
Net Calls Change
+$15K

MNOV Hedge Fund Activity: Q1 2024 in Review

35 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2024, worth a combined $6.78M — down 6.5% from $7.25M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MNOV positions and 4 closed out — a net gain of 1 holder — while 6 added to existing stakes and 13 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $79.9K. The largest seller was JP Morgan Chase, cutting an estimated $142K.

  • 35 institutional investors held MediciNova (MNOV) as of Q1 2024, up from 34 in Q4 2023.
  • Funds reported $6.78M of MediciNova stock for Q1 2024, down 6.5% quarter-over-quarter.
  • 5 funds opened new MediciNova positions in Q1 2024 and 4 closed out, a net change of +1 holder.
  • The largest MediciNova buyer in Q1 2024 was Renaissance Technologies, an estimated $79.9K added.
  • The largest MediciNova seller in Q1 2024 was JP Morgan Chase, an estimated $142K sold.

Based on aggregated 13F filings for Q1 2024.